Surfactant: The Basis for Clinical Treatment Strategies

The Newborn Lung: Neonatology Questions and Controversies

Volumn , Issue , 2008, Pages 73-98

  Jobe, Alan H ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956632912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141603166-6.10004-X     Document Type: Chapter

References (79)

1. JD Horbar, EC Wright, L Onstad, et al. (1993) Decreasing mortality associated with the introduction of surfactant therapy: an observed study of neonates weighing 601 to 1300 grams at birth. Pediatrics 92
2. RM Schwartz, AM Luby, JW Scanlon, et al. (1994) Effect of surfactant on morbidity, mortality, and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med 330 1476-1480
3. RF Soll (2001) Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database of Systematic Reviews 3
4. AH Jobe and M Ikegami (2001) Biology of surfactant. Clin Perinatol 28 655-669
5. A Jobe and M Ikegami (1987) Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 136 1256-1275
6. PW Burri (1985) Development and growth of the human lung. AP Fishman, AB Fisher,(Eds) Handbook of physiology: the respiratory system Bethesda, MD: American Physiologic Society 1-46
7. AA Hislop, JS Wigglesworth and R Desai (1986) Alveolar development in the human fetus and infant. Early Hum Dev 13 1-11
8. MV Kulovich, M Hallman and L Gluck (1979) The lung profile: normal pregnancy. Am J Obstet Gynecol 135 57-63
9. GS Pryhuber, WM Hull, I Fink, et al. (1991) Ontogeny of surfactant protein-A and protein-B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 30 597-605
10. L Gluck, M Kulovich, RC Borer, et al. (1971) Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 109 440-445
11. PL Ballard, LW Gonzales, RI Godinez, et al. (2006) Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 59 157-162
12. T Ueda, M Ikegami and AH Jobe (1994) Developmental changes of sheep surfactant: in vivo function and in vitro subtype conversion. J Appl Physiol 76 2701-2706
13. JA Whitsett and TE Weaver (2002) Hydrophobic surfactant proteins in lung function and disease. N Engl J Med 347 2141-2148
14. JE Bunt, LJ Zimmerman, D Wattimena, et al. (1998) Endogenous surfactant turnover in preterm infants measured with stable isotope. Am J Respir Crit Care Med 157 810-814
15. M Torresin, LJ Zimmermann, PE Cogo, et al. (2000) Exogenous surfactant kinetics in infant respiratory distress syndrome: A novel method with stable isotopes. Am J Respir Crit Care Med 161: 1584-1589
16. AH Jobe (2003) Surfactant metabolism in newborns - insights from imprecise measurements. Pediatrics 142 223-224
17. JC Jackson, S Palmer, WE Truog, et al. (1986) Surfactant quantity and composition during recovery from hyaline membrane disease. Pediatr Res 20 1243-1247
18. PE Cogo, GM Toffolo, A Gucciardi, et al. (2005) Surfactant disaturated phosphatidylcholine kinetics in infants with bronchopulmonary dysplasia measured with stable isotopes and a two-compartment model. J Appl Physiol 99 323-329
19. M Ikegami, A Jobe, T Yamada, et al. (1989) Surfactant metabolism in surfactant-treated preterm ventilated lambs. J Appl Physiol 67 429-437
20. M Ikegami, H Jacobs and AH Jobe (1983) Surfactant function in the respiratory distress syndrome. J Pediatr 102 443-447
21. B Robertson, D Berry, T Curstedt, et al. (1985) Leakage of protein in the immature rabbit lung; effect of surfactant replacement. Respir Physiol 61 265-276
22. DL Shapiro, RH Notter, FCD Morin, et al. (1985) Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Pediatrics 76 593-599
23. H Verder, P Albertsen, F Ebbesen, et al. (1999) Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 103 E24
24. A Ammari, MS Suri, V Milisavljevic, et al. (2005) Variables associated with the early failure of nasal CPAP in very low birth weight infants. J Pediatr 147 341-347
25. H Aly, AN Massaro, K Patel, et al. (2005) Is it safer to intubate premature infants in the delivery room? Pediatrics 115 1660-1665
26. JD Horbar, JH Carpenter, J Buzas, et al. (2004) Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based? Pediatrics 113 1593-1602
27. N Mulrooney, Z Champion, TJ Moss, et al. (2005) Surfactant and physiological responses of preterm lambs to continuous positive airway pressure. Am J Respir Crit Care Med 171 488-493
28. AH Jobe (1998) Surfactant-edema interactions. EK Weir, JT Reeves,(Eds) The pathogenesis and treatment of pulmonary edema Armonk, NY: Futura Publishing 113-131
29. M Ikegami, A Jobe and T Glatz (1981) Surface activity following natural surfactant treatment in premature lambs. Am J Physiol Lung Cell Mol Physiol 51 L306-L312
30. SR Seidner, M Ikegami, T Yamada, et al. (1995) Decreased surfactant dose-response after delayed administration to preterm rabbits. Am J Respir Crit Care Med 152 113-120
31. AH Jobe, M Ikegami, SR Seidner, et al. (1989) Surfactant phosphatidylcholine metabolism and surfactant function in preterm, ventilated lambs. Am Rev Respir Dis 139 352-359
32. P Crowley (1995) Antenatal corticosteroid therapy: a meta-analysis of the randomized trials - 1972-1994. Am J Obstet Gynecol 173 322-335
33. PL Ballard, Y Ning, D Polk, et al. (1997) Glucocorticoid regulation of surfactant components in immature lambs. Am J Physiol 273 L1048-L1057
34. M Ikegami, D Berry, T Elkady, et al. (1987) Corticosteroids and surfactant change lung function and protein leaks in the lungs of ventilated premature rabbits. J Clin Invest 79 1371-1378
35. KE Willet, P McMenamin, KE Pinkerton, et al. (2000) Lung morphometry and collagen and elastin content: changes during normal development and after prenatal hormone exposure in sheep. Pediatr Res 45 615-625
36. M Ikegami, D Polk, B Tabor, et al. (1991) Corticosteroid and thyrotropin-releasing hormone effects on preterm sheep lung function. J Appl Physiol 70 2268-2278
37. M Ikegami, AH Jobe, T Yamada, et al. (1989) Relationship between alveolar saturated phosphatidylcholine pool sizes and compliance of preterm rabbit lungs. The effect of maternal corticosteroid treatment. Am Rev Respir Dis 139 367-369
38. S Seidner, A Pettenazzo, M Ikegami, et al. (1988) Corticosteroid potentiation of surfactant dose response in preterm rabbits. J Appl Physiol 64 2366-2371
39. CM Rebello, M Ikegami, DH Polk, et al. (1996) Postnatal lung responses and surfactant function after fetal or maternal corticosteroid treatment of preterm lambs. J Appl Physiol 80 1674-1680
40. AH Jobe, BR Mitchell and JH Gunkel (1993) Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 168 508-513
41. A Charon, HW Taeusch, C Fitzgibbon, et al. (1989) Factors associated with surfactant treatment response in infants with severe respiratory distress syndrome. Pediatrics 83 348-354
42. D Berry, A Jobe, H Jacobs, et al. (1985) Distribution of pulmonary blood flow in relation to atelectasis in premature ventilated lambs. Am Rev Respir Dis 132 500-503
43. A Jobe (1995) Techniques for administering surfactant. B Robertson,(Eds) Surfactant therapy for lung disease, vol 84 New York: Marcel Dekker 309-324
44. T Ueda, M Ikegami, ED Rider, et al. (1994) Distribution of surfactant and ventilation in surfactant-treated preterm lambs. J Appl Physiol 76 45-55
45. A Jobe, M Ikegami, H Jacobs, et al. (1984) Surfactant and pulmonary blood flow distributions following treatment of premature lambs with natural surfactant. J Clin Invest 73 848-856
46. EM Zola, JH Gunkel, RK Chan, et al. (1993) Comparison of three dosing procedures for administration of bovine surfactant to neonates with respiratory distress syndrome. J Pediatr 122 453-459
47. EM Zola, AM Overbach, JH Gunkel, et al. (1993) Treatment Investigational New Drug experience with Survanta (beractant). Pediatrics 91 546-551
48. G Enhorning, A Shennan, F Possmayer, et al. (1985) Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: a randomized clinical trial. Pediatrics 76 145-153
49. G Enhörning, G Grossman and B Robertson (1973) Tracheal deposition of surfactant before the first breath. Am Rev Respir Dis 107 921-927
50. D Robertson (1984) Pathology and pathophysiology of neonatal surfactant deficiency. B Robertson, et al., (Eds) Pulmonary surfactant Amsterdam: Elsevier Science Publishers
51. JW Kendig, RH Notter, C Cox, et al. (1988) Surfactant replacement therapy at birth: final analysis of a clinical trial and comparisons with similar trials. Pediatrics 82 756-762
52. JW Kendig, RM Ryan, RA Sinkin, et al. (1998) Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial. Pediatrics 101 1006-1012
53. RF Soll and C Morley (2001) Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants. The Cochrane Library, Issue 2 Oxford: Update Software
54. JD Horbar, JH Carpenter, J Buzas, et al. (2004) Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial. Br Med J 329 1004
55. NN Finer, WA Carlo, S Duara, et al. (2004) Delivery room continuous positive airway pressure/positive end-expiratory pressure in extremely low birth weight infants: a feasibility trial. Pediatrics 114 651-657
56. AH Jobe (2005) Transition/Adaptation in the delivery room and less RDS: don't just do something, stand there!. J Pediatr 147 284-286
57. RF Soll, RE Hoekstra, JJ Fangman, et al. (1990) Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics 85 1092-1102
58. RF Soll, TA Merritt and M Hallman (1994: 49-80) Surfactant in the prevention and treatment of respiratory distress syndrome. BR Boynton, WA Carlo, AH Jobe,(Eds) New therapies for neonatal respiratory failure Cambridge: Cambridge University Press
59. AH Jobe (1993) Pulmonary surfactant therapy. N Eng J Med 328 861-868
60. Early versus delayed neonatal administration of a synthetic surfactant - the judgment of OSIRIS (1992) The OSIRIS Collaborative Group (open study of infants at high risk of or with respiratory insufficiency - the role of surfactant. Lancet 340 1363-1369
61. JF Lewis and AH Jobe (1993) Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 147 218-233
62. E Herting, P Rauprich, G Stichtenoth, et al. (2001) Resistance of different surfactant preparations to inactivation by meconium. Pediatr Res 50 44-49
63. RD Findlay, WH Taeusch and FJ Walther (1996) Surfactant replacement therapy for meconium aspiration syndrome. Pediatr 97 48-52
64. RL Auten, RH Notter, JW Kendig, et al. (1991) Surfactant treatment of full-term newborns with respiratory failure. Pediatrics 87 101-107
65. A Lotze, BR Mitchell, DI Bulas, et al. (1998) Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure. Survanta in Term Infants Study Group. J Pediatr 132 40-47
66. TE Wiswell, GR Knight, NN Finer, et al. (2002) A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome. Pediatrics 109 1081-1087
67. Chinese Collaborative Study Group for Neonatal Respiratory Diseases (2005) Treatment of severe meconium aspiration syndrome with porcine surfactant: a multicentre, randomized, controlled trial. Acta Paediatr 94 896-902
68. M Szymankiewicz, J Gadzinowski and K Kowalska (2004) Pulmonary function after surfactant lung lavage followed by surfactant administration in infants with severe meconium aspiration syndrome. J Matern Fetal Neonatal Med 16 125-130
69. JD Merrill, RA Ballard, A Cnaan, et al. (2004) Dysfunction of pulmonary surfactant in chronically ventilated premature infants. Pediatr Res 56 918-926
70. PE Cogo, LJ Zimmermann, R Pesavento, et al. (2003) Surfactant kinetics in preterm infants on mechanical ventilation who did and did not develop bronchopulmonary dysplasia. Crit Care Med 31 1532-1538
71. AJ Bhatt, GS Pryhuber, H Huyck, et al. (2001) Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1 and Tie-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164 1971-1980
72. PB Pandit, MS Dunn, EN Kelly, et al. (1995) Surfactant replacement in neonates with early chronic lung disease. Pediatrics 95 851-854
73. A Jobe (2003) Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol 8 9-17
74. E Herting, O Gefeller, M Land, et al. (2000) Surfactant treatment of neonates with respiratory failure and Group B streptococcal infection. Pediatr 106 957-964
75. RG Spragg, JF Lewis, W Wurst, et al. (2003) Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 167 1562-1566
76. SB Ainsworth, MW Beresford, DWA Milligan, et al. (2000) Randomized Controlled Trial of Early Treatment of Respiratory Distress Syndrome with Pumactant (ALEC) or Poractant Alfa (Curosurf) in Infants of 25 to 29 Weeks Gestation. The Lancet 355 1387-1392
77. FR Moya, J Gadzinowski, E Bancalari, et al. (2005) A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 115 1018-1029
78. SK Sinha, T Lacaze-Masmonteil, A Valls i Soler, et al. (2005) A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome. Pediatrics 115 1030-1038
79. BT Bloom and RH Clark (2005) Comparison of Infasurf (calfactant) and Survanta (beractant) in the prevention and treatment of respiratory distress syndrome. Pediatrics 116 392-399